Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Blood|October 13, 2011
Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemiaPekka Jaako, Johan Flygare, Karin Olsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008Magnus Björkholm, Lotta Ohm, Sandra Eloranta, et al.
European Journal of Haematology|July 19, 2016
Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML registerStina Söderlund, Torsten Dahlén, Fredrik Sandin, et al.
British Journal of Haematology|March 31, 2015
Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor eraNiklas Gunnarsson, Leif Stenke, Martin Höglund, et al.
Stem Cells and Development|December 1, 2007
Alpha10 integrin expression is up-regulated on fibroblast growth factor-2-treated mesenchymal stem cells with improved chondrogenic differentiation potentialLaura Varas, Lars Bryngelson Ohlsson, Gabriella Honeth, et al.
Blood|January 1, 2005
Deficiency of ribosomal protein S19 in CD34+ cells generated by siRNA blocks erythroid development and mimics defects seen in Diamond-Blackfan anemiaJohan Flygare, Thomas Kiefer, Koichi Miyake, et al.
American Journal of Hematology|January 11, 2022
Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow-up of patients diagnosed 2002-2017 in a complete coverage and nationwide agnostic register studyTorsten Dahlén, Gustaf Edgren, Per Ljungman, et al.
Bone|August 3, 2013
Lentiviral gene transfer of TCIRG1 into peripheral blood CD34(+) cells restores osteoclast function in infantile malignant osteopetrosisIlana Moscatelli, Christian Schneider Thudium, Carmen Flores, et al.
Blood|January 27, 2017
Single-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CMLRebecca Warfvinge, Linda Geironson, Mikael N E Sommarin, et al.
European Journal of Internal Medicine|August 15, 2016
Management and monitoring recommendations for the use of eliglustat in adults with type 1 Gaucher disease in EuropeNadia Belmatoug, Maja Di Rocco, Cristina Fraga, et al.
Pageof 11